CA1181694A - Compositions pharmaceutiques contenant de l'almitrine - Google Patents

Compositions pharmaceutiques contenant de l'almitrine

Info

Publication number
CA1181694A
CA1181694A CA000383989A CA383989A CA1181694A CA 1181694 A CA1181694 A CA 1181694A CA 000383989 A CA000383989 A CA 000383989A CA 383989 A CA383989 A CA 383989A CA 1181694 A CA1181694 A CA 1181694A
Authority
CA
Canada
Prior art keywords
almitrine
doses
ventilation
respiratory
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000383989A
Other languages
English (en)
French (fr)
Inventor
Francoise Arnaud
Etienne Labeyrie
Jean-Pierre Poirier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Application granted granted Critical
Publication of CA1181694A publication Critical patent/CA1181694A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000383989A 1980-08-18 1981-08-17 Compositions pharmaceutiques contenant de l'almitrine Expired CA1181694A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine
FR80.18074 1980-08-18

Publications (1)

Publication Number Publication Date
CA1181694A true CA1181694A (fr) 1985-01-29

Family

ID=9245242

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000383989A Expired CA1181694A (fr) 1980-08-18 1981-08-17 Compositions pharmaceutiques contenant de l'almitrine

Country Status (14)

Country Link
US (1) US4364946A (https=)
AU (1) AU550741B2 (https=)
BE (1) BE890011A (https=)
CA (1) CA1181694A (https=)
CH (1) CH650152A5 (https=)
DE (1) DE3132654A1 (https=)
FR (1) FR2488509A1 (https=)
GB (1) GB2082064B (https=)
GR (1) GR75328B (https=)
IE (1) IE52095B1 (https=)
IT (1) IT1171461B (https=)
LU (1) LU83556A1 (https=)
NZ (1) NZ198062A (https=)
ZA (1) ZA815664B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
KR20120048659A (ko) * 2009-07-31 2012-05-15 엠티에스 시스템즈 코포레이숀 풍력 터빈 구동 트레인 테스트 조립체
US12410143B2 (en) 2017-01-17 2025-09-09 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
BR112019028172A2 (pt) * 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256513A (https=) * 1968-10-02 1971-12-08

Also Published As

Publication number Publication date
US4364946A (en) 1982-12-21
AU7427781A (en) 1982-02-25
IE52095B1 (en) 1987-06-10
FR2488509A1 (fr) 1982-02-19
GR75328B (https=) 1984-07-13
IE811891L (en) 1982-02-18
LU83556A1 (fr) 1982-04-14
NZ198062A (en) 1983-12-16
BE890011A (fr) 1982-02-18
GB2082064B (en) 1985-06-26
FR2488509B1 (https=) 1984-11-23
ZA815664B (en) 1982-08-25
DE3132654A1 (de) 1982-06-24
IT1171461B (it) 1987-06-10
IT8149104A1 (it) 1983-02-13
IT8149104A0 (it) 1981-08-13
CH650152A5 (fr) 1985-07-15
AU550741B2 (en) 1986-04-10
GB2082064A (en) 1982-03-03

Similar Documents

Publication Publication Date Title
Hales et al. Influence of aspirin and indomethacin on variability of alveolar hypoxic vasoconstriction
NZ588505A (en) Dosing regimen for a selective S1P1 receptor agonist (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-o-tolyl-thiazolidin-4-one
WO2002026223A3 (en) Catecholamine pharmaceutical compositions and methods
US20140271890A1 (en) Controlled-release pharmaceutical composition
AU2003229724B2 (en) Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
CA1181694A (fr) Compositions pharmaceutiques contenant de l'almitrine
CN108619138B (zh) 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途
CN109172550B (zh) 一种复合麻醉药物
Chapleu et al. Chemoreceptor stimulation interferes with regional hypoxic pulmonary vasoconstriction
CN112569220B (zh) 四氢次大麻酚在制备用于治疗肺动脉高压药物中的应用及含有四氢次大麻酚的药物组合物
RU2174838C2 (ru) Способ лечения тяжелого бронхообструктивного синдрома у детей раннего возраста
Parratt The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at β‐adrenoceptors: comparison with propranolol
Iwata et al. Catecholamine accumulation in tissues of thiamine-deficient rats after inhibition of monoamine oxidase
JP2013529211A (ja) 高地低酸素症の処置
CA2417758C (en) Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
AU2007248654B2 (en) Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
Korokina et al. Principles of pharmacological correction of pulmonary arterial hypertension. Research Results in Pharmacology, 4 (2): 59-76
CA2368616A1 (en) Use of vasopeptidase inhibitors to treat angina pectoris
WO2019131308A1 (ja) ９‐β‐Ｄ‐アラビノフラノシルヒポキサンチンによる不整脈治療
JP2835881B2 (ja) 血流改善剤
US6201015B1 (en) Therapeutic method for thrombocytopathy treatment
Elo et al. Anesthesia and Sedation
Parker et al. Blood pressure overshoot under pentobarbitone anaesthesia following a single dose of clonidine in rats
SU1094610A1 (ru) Способ лечени ожоговой болезни
SU1673120A1 (ru) Способ лечени приступного периода бронхиальной астмы у детей

Legal Events

Date Code Title Description
MKEX Expiry